Avidity Biosciences, Inc. short interest in 2023
In 2023, Avidity Biosciences, Inc.'s disclosed short interest ran from 14.45% of shares outstanding on 13 Jan 2023 to 13.26% on 29 Dec 2023, a change of -1.19 percentage points. The year's high was 22.66% on 14 Jul 2023 and its low 11.13% on 15 Feb 2023, averaging 16.98% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 32.55 days on 14 Jul 2023. Full history: Avidity Biosciences, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025
2023 in figures
- Start of year
- 14.45% (13 Jan 2023)
- End of year
- 13.26% (29 Dec 2023)
- Change
- -1.19 pp
- High
- 22.66% (14 Jul 2023)
- Low
- 11.13% (15 Feb 2023)
- Average
- 16.98%
- Highest days to cover
- 32.55 (14 Jul 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 14.45% | 8.58 | |
| 31 Jan 2023 | 13.76% | 10.78 | |
| 15 Feb 2023 | 11.13% | 11.27 | |
| 28 Feb 2023 | 11.73% | 9.93 | 10-K filed, results (8-K) |
| 15 Mar 2023 | 12.27% | 9.08 | |
| 31 Mar 2023 | 15.41% | 6.52 | |
| 14 Apr 2023 | 16.01% | 8.02 | |
| 28 Apr 2023 | 14.02% | 6.32 | |
| 15 May 2023 | 18.12% | 8.54 | 10-Q filed, results (8-K) |
| 31 May 2023 | 18.93% | 14.55 | |
| 15 Jun 2023 | 19.91% | 11.43 | |
| 30 Jun 2023 | 22.19% | 8.99 | |
| 14 Jul 2023 | 22.66% | 32.55 | |
| 31 Jul 2023 | 21.09% | 23.93 | |
| 15 Aug 2023 | 21.68% | 24.60 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 22.10% | 28.07 | |
| 15 Sep 2023 | 22.56% | 12.57 | |
| 29 Sep 2023 | 20.90% | 20.31 | |
| 13 Oct 2023 | 15.61% | 14.02 | |
| 31 Oct 2023 | 15.66% | 17.89 | |
| 15 Nov 2023 | 14.66% | 16.46 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 14.88% | 3.40 | |
| 15 Dec 2023 | 14.41% | 7.52 | |
| 29 Dec 2023 | 13.26% | 10.19 |
See also: Avidity Biosciences, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.